Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Christopher T Ritchlin

53PUBLICATIONS
119CO-AUTHORS
Tissue engineeringRheumatology and arthritisPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tribology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

Sort by Publication Date:
|Jun 15, 2026
Synovial Telocytes are Characterized by Efhd1, Dpp4, and Pi16 Expression, Show High Responsiveness to Osmotic Stress, and Exhibit Fibroblast Plasticity Potential.

|May 05, 2026
Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic Arthritis.

|Mar 25, 2026
Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study.

Jose U Scher, Iain B McInnes, Enrique R Soriano

|Mar 16, 2026
Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.

Laure Gossec, Laura C Coates, Robert B M Landewé

|Mar 16, 2026
Telocyte Deletion Associated With Loss of Lymphatic Drainage and Exacerbation of Inflammatory-Erosive Arthritis in Mice.

Yue Peng, H Mark Kenney, Sean Lydon

|Feb 11, 2026
Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of a Phase 3, Randomized, Placebo-Controlled Study.

Alexis Ogdie, Joseph F Merola, Philip J Mease

Pageof 9

Frequent Collaborators

20 joint publications

Phillip J Mease

11 joint publications

Laura C Coates

9 joint publications

Alexis Ogdie

9 joint publications

Oliver FitzGerald

9 joint publications

Philip S Helliwell

9 joint publications

Iain B McInnes

8 joint publications

Jose U Scher

6 joint publications

Stephen R Pennington

6 joint publications

Soumya D Chakravarty

6 joint publications

Dafna D Gladman

Frequent Collaborators

20 joint publications

Phillip J Mease

11 joint publications

Laura C Coates

9 joint publications

Alexis Ogdie

9 joint publications

Oliver FitzGerald